WS #3777

The dominant signal in this 10-minute window is escalating geopolitical and energy market stress, with multiple high-impact developments corroborating significant market-moving risks. Geopolitical tensions are intensifying, as evidenced by a jetstream.bsky.priority report that the United States is in serious talks with Iran's new regime to end military operations, but with a threat to "completely destroy" Iran's power plants, oil fields, and desalination facilities if a deal isn't reached soon. This aligns with earlier context about Strait of Hormuz disruptions, and is further supported by a separate jetstream report that Ukraine has discussed unblocking the Strait of Hormuz with Gulf countries, indicating regional navigation risks. Concurrently, energy and commodity markets are showing acute stress: oil shipping rates are surging as US barrels replace Middle East supply, aluminum prices have broken out with LME up 6% to $3,492/t due to Gulf smelter disruptions, and European aluminum premiums hit 19-year highs. These supply shocks are colliding with monetary policy concerns, as Treasury yields sell off with the 5-year above 4%, crushing rate cut bets and driving a risk-off move across equities, with VIX at 31.07. In corporate developments, significant biopharma news includes Biogen's FDA approval of a high-dose regimen for SPINRAZA, which could positively impact BIIB. Terrestrial Energy reported a quarterly EPS beat, though this is less impactful than the broader energy narrative. Several other biotech updates, such as Alterity Therapeutics receiving positive FDA feedback and PDS Biotechnology reporting early positive cancer results, provide stock-specific catalysts but are lower significance compared to the macro shocks. The energy crisis remains the highest-signal cluster, with cross-source corroboration from geopolitical reports, commodity price movements, and shipping data pointing to sustained inflationary pressures and potential equity market volatility.